Your browser doesn't support javascript.
loading
An Exploratory Study for the Association of Gut Microbiome with Efficacy of Immune Checkpoint Inhibitor in Patients with Hepatocellular Carcinoma.
Shen, Ying-Chun; Lee, Pei-Chang; Kuo, Yu-Lun; Wu, Wei-Kai; Chen, Chieh-Chang; Lei, Chengh-Hau; Yeh, Ching-Ping; Hsu, Chiun; Hsu, Chih-Hung; Lin, Zhong-Zhe; Shao, Yu-Yun; Lu, Li-Chun; Liu, Tsung-Hao; Chen, Chien-Hung; Wu, Ming-Shiang; Huang, Yi-Hsiang; Cheng, Ann-Lii.
Afiliación
  • Shen YC; Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan.
  • Lee PC; Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Kuo YL; Institute of Pharmacology, National Yang-Ming University School of Medicine, Taipei, Taiwan.
  • Wu WK; Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Chen CC; Biotools Co., Ltd, New Taipei City, Taiwan.
  • Lei CH; Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan.
  • Yeh CP; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Hsu C; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Hsu CH; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.
  • Lin ZZ; Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan.
  • Shao YY; Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Lu LC; Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Liu TH; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.
  • Chen CH; Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan.
  • Wu MS; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.
  • Huang YH; Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Cheng AL; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.
J Hepatocell Carcinoma ; 8: 809-822, 2021.
Article en En | MEDLINE | ID: mdl-34336726
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: J Hepatocell Carcinoma Año: 2021 Tipo del documento: Article País de afiliación: Taiwán
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: J Hepatocell Carcinoma Año: 2021 Tipo del documento: Article País de afiliación: Taiwán